Diagnosis of Hunter Syndrome (Mucopolysaccharidosis Type II) in a Resource­ Limited Setting: A Case Report from Zambia

Authors

  • Lweendo Nchimba Lusaka Apex Medical University, School of Medicine
  • Evans Mwila Mpabalwani Arthur Davison Children's Hospital and Copperbelt University, Ndola, Zambia
  • Muleya Inambao Arthur Davison Children's Hospital, Lusaka, Zambia
  • Nfwama Kawatu University Teaching Hospitals - Children's Hospital, Lusaka, Zambia

DOI:

https://doi.org/10.55320/mjz.48.3.183

Keywords:

Hunter Syndrome, Clinical Features, Child, Mucopolysaccharidosis, Zambia

Abstract

Abstract

Hunter syndrome is one of the Mucopolysaccharidosis (MPS), type II. It is a rare genetic disorder due to a deficiency in the enzyme Iduronate 2-sulphatase. This deficiency leads to the accumulation of glycosaminoglycans (GAGs) dermatan sulphate and heparan sulphate. The GAGs accumulate both intracellularly and extracellularly, leading to abnormalities in different organ systems in the body. The definitive diagnosis of Hunter syndrome requires biochemical methods which can be a challenge in resource-limited settings, Zambia included.  Presented here is a case of Hunter Syndrome in a 12-year-old male child and highlight clinical acumen as the main ingredient in making the diagnosis and distinguishing different types.

Downloads

Download data is not yet available.

Downloads

Published

12-01-2022

Issue

Section

Case Report

How to Cite

Diagnosis of Hunter Syndrome (Mucopolysaccharidosis Type II) in a Resource­ Limited Setting: A Case Report from Zambia. (2022). Medical Journal of Zambia, 48(3), 335-338. https://doi.org/10.55320/mjz.48.3.183

Similar Articles

51-60 of 322

You may also start an advanced similarity search for this article.